¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇÑ ÆÄŲ½¼º´ ¹× ÀÌ»ó¿îµ¿Áúȯ ÇÐȸ(KMDS) 2023 Ãá°èÇмú´ëȸ(1ÀÏÂ÷) : 2023-04-29

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

´ëÇÑ ÆÄŲ½¼º´ ¹× ÀÌ»ó¿îµ¿Áúȯ ÇÐȸ(KMDS) 2023 Ãá°èÇмú´ëȸ(1ÀÏÂ÷) : 2023-04-29
±³À°ÀÏÀÚ : 2023-04-29
±³À°Àå¼Ò : ´õÄÉÀÌÈ£ÅÚ¼­¿ï °Å¹®°íȦ

±³À°ÁÖÁ¦ : ´ëÇÑ ÆÄŲ½¼º´ ¹× ÀÌ»ó¿îµ¿Áúȯ ÇÐȸ(KMDS) 2023 Ãá°èÇмú´ëȸ(1ÀÏÂ÷)

ÁÖÃÖ±â°ü : ´ëÇÑÆÄŲ½¼º´¹×ÀÌ»ó¿îµ¿ÁúȯÇÐȸ
´ã´çÀÚ : Ãֹ̼Ò
¿¬¶ôó : 02-6395-2876  

À̸ÞÀÏ : movement@kmds.or.kr

±³À°Á¾·ù : ½Å°æ°ú

Âü¼®¿¹»óÀÎ : 100¸í
Èñ¸ÁÆòÁ¡ : 6Á¡

Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 6 ½Ã°£ 25ºÐ

¼¼ºÎ¼ö°­·á : 160,000¿ø  

ºñ°í »çÀüµî·Ï : 80,000¿ø / ÁØȸ¿ø 50,000¿ø / ºñȸ¿ø Àü¹®ÀÇ 160,000¿ø / ºñȸ¿ø Àü°øÀÇ 60,000¿ø ÇöÀåµî·Ï : Çмú´ëȸ : Á¤È¸¿ø 100,000¿ø / ÁØȸ¿ø 60,000¿ø / ºñȸ¿ø Àü¹®ÀÇ 200,000¿ø / ºñȸ¿ø Àü°øÀÇ 70,000¿ø

±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 04¿ù 29ÀÏ ´õÄÉÀ̼­¿ïÈ£ÅÚ °Å¹®°íȦ 09:00~09:35 Treatment Based on Semiology or on Genetics or Both? : Focus on Dystonia Marie Vidailhet(Hôpital de la Pitié-Salpêtrière Paris France)

±³À°½Ã°£ 04¿ù 29ÀÏ ´õÄÉÀ̼­¿ïÈ£ÅÚ °Å¹®°íȦ 09:35~10:10 Surgical Treatment for Movement Disorders Alfonso Fasano(University of Toronto Canada)

Åä·Ð 04¿ù 29ÀÏ ´õÄÉÀ̼­¿ïÈ£ÅÚ °Å¹®°íȦ 10:10~10:15 Q&A ¹éÁ¾»ï(ÀÎÁ¦ÀÇ´ë)

ÈÞ½Ä 04¿ù 29ÀÏ 10:15~10:25 ÈÞ½Ä ( )

±³À°½Ã°£ 04¿ù 29ÀÏ ´õÄÉÀ̼­¿ïÈ£ÅÚ °Å¹®°íȦ 10:25~10:55 Mechanism and Application of Immunologic Treatment for Movement Disorders À̼øÅÂ(¼­¿ïÀÇ´ë)

±³À°½Ã°£ 04¿ù 29ÀÏ ´õÄÉÀ̼­¿ïÈ£ÅÚ °Å¹®°íȦ 10:55~11:25 Updates in Rehabilitation for Parkinson Àå¿øÇõ(¼º±Õ°üÀÇ´ë ÀçÈ°ÀÇÇаú)

Åä·Ð 04¿ù 29ÀÏ ´õÄÉÀ̼­¿ïÈ£ÅÚ °Å¹®°íȦ 11:25~11:30 Q&A Á¶Áøȯ(¼º±Õ°üÀÇ´ë)

±³À°½Ã°£ 04¿ù 29ÀÏ ´õÄÉÀ̼­¿ïÈ£ÅÚ °Å¹®°íȦ 11:30~12:10 Genetic Landscape of Parkinson''s Disease ±èÀ±Áß(¿¬¼¼ÀÇ´ë)

½Ä»ç 04¿ù 29ÀÏ 12:10~13:05 ½Ä»ç ( )

Åä·Ð 04¿ù 29ÀÏ ´õÄÉÀ̼­¿ïÈ£ÅÚ °Å¹®°íȦ 13:05~14:00 Poster Session : Guided Poster Tour ±è¿µÀº ¿ÀÀÀ¼® Àå¿ì¿µ(ÇѸ²ÀÇ´ë Ãæ³²ÀÇ´ë ¿ï»êÀÇ´ë)

±³À°½Ã°£ 04¿ù 29ÀÏ ´õÄÉÀ̼­¿ïÈ£ÅÚ °Å¹®°íȦ 14:00~14:30 Nigrosome 1, Neuromelanin, and Novel Imaging Analysis for Movement Disorders ±èÀÀ¿±(¼º±Õ°üÀÇ´ë ¿µ»óÀÇÇаú)

±³À°½Ã°£ 04¿ù 29ÀÏ ´õÄÉÀ̼­¿ïÈ£ÅÚ °Å¹®°íȦ 14:30~15:00 Digital Biomarker for Movement Disorders ¹ÚÁø¼¼(ÀÎÁ¦ÀÇ´ë)

±³À°½Ã°£ 04¿ù 29ÀÏ ´õÄÉÀ̼­¿ïÈ£ÅÚ °Å¹®°íȦ 15:00~15:30 Imaging and Laboratory Tests in the Diagnosis of MSA and DLB À¯ÇѼö(¿¬¼¼ÀÇ´ë)

ÈÞ½Ä 04¿ù 29ÀÏ 15:30~15:40 ÈÞ½Ä ( )

±³À°½Ã°£ 04¿ù 29ÀÏ ´õÄÉÀ̼­¿ïÈ£ÅÚ °Å¹®°íȦ 15:40~16:00 Drug Repurposing in Movement Disorder À̸íÁØ(ºÎ»êÀÇ´ë)

±³À°½Ã°£ 04¿ù 29ÀÏ ´õÄÉÀ̼­¿ïÈ£ÅÚ °Å¹®°íȦ 16:00~16:20 Pathologic Alpha-synuclein Protein Targeting Antibody Immunotherapy ¾È¼º¿ø(ABL Bio)

±³À°½Ã°£ 04¿ù 29ÀÏ ´õÄÉÀ̼­¿ïÈ£ÅÚ °Å¹®°íȦ 16:20~16:40 CBD Oil and Glutathione for PD: Do they Work? À±Áö¿µ(ÀÌÈ­ÀÇ´ë)

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇÑ ÆÄŲ½¼º´ ¹× ÀÌ»ó¿îµ¿Áúȯ ÇÐȸ(KMDS) 2023 Ãá°èÇмú´ëȸ(1ÀÏÂ÷) : 2023-04-29""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û 2023 Á¦15Â÷ Ä¡¸ÅÁø·áÀÇ»ç Àü¹®È­ ±³À° (»ó¹Ý±â) -2ÀÏÂ÷- : 2023-04-29
´ÙÀ½±Û ´ëÇѽÅÀåÇÐȸ KSN(Korea Society of Nephrology) 2023 (3ÀÏÂ÷) : 2023-04-29
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
1217 ¼­¿ï 2018 ´ëÇѺñ´¢±â°úÇÐȸ Á¦70Â÷ Ãß°èÇмú´ëȸ : 2018-11-30 0 2,619 2018-09-28
1216 ¼­¿ï °­³²¼¼ºê¶õ½ºº´¿ø À̺ñÀÎÈÄ°ú Áö¿ªÀÇ»ç Áý´ãȸ : 2018-11-29 0 508 2018-09-28
1215 ¼­¿ï ¼¼ºê¶õ½ºº´¿ø À̺ñÀÎÈÄ°ú 2Çбâ Áö¿ªÀÇ»çÁý´ãȸ(±â¸³¼º ¾îÁö·³Áõ) : 2018-11-29 0 762 2018-09-28
1214 ¼­¿ï 2018 ´ëÇѺñ´¢±â°úÇÐȸ Á¦70Â÷ Ãß°èÇмú´ëȸ : 2018-11-29 0 1,128 2018-09-28
1213 ´ëÀü °¡Å縯´ëÇб³´ëÀü¼º¸ðº´¿ø Á¦6ȸ °³¿øÀǸ¦ À§ÇÑ ½ÉÀüµµ ±³À° ½ÉÆ÷Áö¾ö : 2018-11-28 0 2,173 2018-09-28
1212 ¼­¿ï ¼­¿ï¾Æ»êº´¿ø ¼ÛÆı¸(5Â÷) °³¿øÀÇ ¿¬¼ö±³À°(¼Òº¯¹®Á¦, °í¿ä»êÇ÷Áõ) : 2018-11-27 0 1,241 2018-09-28
1211 ¼­¿ï °­³²¼¼ºê¶õ½ºº´¿ø ¾È°ú Áö¿ªÀÇ»ç Áý´ãȸ(¸Á¸·Áúȯ) : 2018-11-27 0 1,016 2018-09-28
1210 °æ±â Â÷ÀÇ°úÇдëÇб³ºÐ´çÂ÷º´¿ø °¢¸· ¹× Àü¾ÈºÎ : 2018-11-27 0 785 2018-09-28
1209 ¼­¿ï ÀÌÈ­¿©ÀÚ´ëÇб³ÀÇ´ëºÎ¼Ó¸ñµ¿º´¿ø ÀÎÈÄ°ú Áö¿ªÀÇ»ç Áý´ãȸ : 2018-11-27 0 582 2018-09-28
1208 ¼­¿ï »ï¼º¼­¿ïº´¿ø ´ëÇÑÀÌ°úÇÐȸ 2018 ÀÌ°úÇÐ Live Surgery ¹× ½ÅÀÇ·á±â¼ú ¼¼¹Ì³ª : 2018-11-25 0 690 2018-09-28
1207 ÀÎõ 2018 °¡Ãµ´ë ±æº´¿ø Facial Surgery Symposium : 2018-11-25 0 1,171 2018-09-28
1206 ¼­¿ï ´ëÇÑ°©»ó¼±³»ºÐºñ¿Ü°úÇÐȸ Ãß°è½ÉÆ÷Áö¾ö : 2018-11-25 0 1,289 2018-09-28
1205 ¼­¿ï »ï¼º¼­¿ïº´¿ø ´ëÇÑÁ¤Çü¿Ü°úÇÐȸ ȸÀü±Ù°³ ÆÄ¿­/¿ªÇ༺ Àΰø °ß°üÀý ġȯ¼ú/°ß¡¤ÁÖ°üÀý °ñÀý : 2018-11-24 0 2,478 2018-09-28
1204 ¼­¿ï 2018 ´ëÇѼöºÎ¿Ü°úÇÐȸ Cadaver Workshop : 2018-11-24 0 1,048 2018-09-28
1203 ºÎ»ê ´ëÇѽÅÀåÇÐȸ Clinical unmet need; Antibody-mediated rejection : 2018-11-24 0 309 2018-09-28
1331 | 1332 | 1333 | 1334 | 1335 | 1336 | 1337 | 1338 | 1339 | 1340
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷